OncoSec Medical Inc

Throwing Field Museum in San Diego, CA, offers visitors a unique experience showcasing the art and history of throwing sports. With interactive exhibits and engaging displays, guests can explore the evolution of various throwing techniques and equipment. The museum is a must-visit for sports enthusiasts and families looking to learn more about this dynamic aspect of athletic competition. Generated from this place's information

Zentalis Pharmaceuticals is a clinical-stage biopharmaceutical company based in New York, NY, dedicated to discovering and developing innovative small molecule therapeutics for the treatment of various cancers. With a focus on targeting fundamental biological pathways of cancer, Zentalis aims to improve the lives of patients by advancing clinically differentiated oncology therapies. Utilizing their integrated discovery engine and deliberate medicinal chemistry, Zentalis is committed to leveraging known cancer biology to develop novel and effective treatments. Their pipeline includes clinical-stage compounds such as Azenosertib, a WEE1 inhibitor, and ZN-d5, a BCL-2 inhibitor, with ongoing clinical trials targeting gynecologic malignancies, ovarian cancer, uterine serous carcinoma, solid tumors, acute myeloid leukemia, and more.Generated from the website

Erasca Inc. is a clinical-stage precision oncology company based in San Diego, dedicated to transforming cancer treatment by targeting the RAS MAPK pathway, which is commonly mutated in various cancers affecting millions globally each year. With a robust and modality-agnostic pipeline, Erasca aims to make a significant impact on the lives of patients through innovative therapeutic programs designed to shut down this critical signaling cascade. Founded in 2018 by Jonathan E. Lim, M.D., Erasca is driven by a mission to erase cancer and is committed to combining serious scientific research with an engaging corporate culture. The company's leadership brings extensive experience in biotechnology and drug delivery, with a proven track record of achieving global regulatory approvals and advancing precision oncology initiatives. Generated from the website